Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]
Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System
Abbott (NYSE: ABT) today announced it’s developing a new biowearable that will continuously monitor glucose and […]
One Million Checks Delivered By NHS ‘One Stop Shops’
NHS ‘one stop shops’ have delivered over one million checks and tests since the rollout […]
Novavax Initiates Phase 3 Trial of its COVID-19 Omicron Strain Vaccine as a Booster
Novavax today announced the initiation of its Phase 3 strain change trial to determine if […]
Tobias Hauser Joins Limbic to Help Close UK Demand-supply Gap of Psychological Therapy
Tobias Hauser, joins Limbic as its Head of Computational Psychiatry. Hauser has worked at the […]
GSK to Acquire Clinical-stage Biopharmaceutical Company Affinivax, Inc.
GSK plc (LSE/NYSE: GSK) today announced that it has entered into a definitive agreement to […]
ETNA™ Device From the Leading Digital Health & AI Company Innodem Neurosciences Receives FDA"Breakthrough" Designation for Multiple Sclerosis
Innodem Neurosciences, a leading provider of innovation and technology for the convergence of neurosciences, digital […]
FDA Approves Roche’s Evrysdi for Use in Babies Under Two Months With Spinal Muscular Atrophy (SMA)
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration […]
Jubilant HollisterStier LLC Enters Into Cooperative Agreement of $149.6 Mn With US Government to Expand Critical Vaccine Manufacturing Capacity
Jubilant Pharmova Limited has announced today that Jubilant Pharma Limited, a wholly owned subsidiary of […]
IASO Biotherapeutics' Equecabtagene Autoleucel, the World's First CAR-T for Treatment of NMOSD, Receives IND Application Acceptance by NMPA
IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more